Keynote Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
697
-8
-1% -$2.97K 0.13% 145
2026
Q1
$206K Sell
705
-30
-4% -$9.86K 0.11% 159
2025
Q4
$258K Sell
735
-25
-3% -$8.45K 0.14% 144
2025
Q3
$246K Sell
760
-5
-0.7% -$1.55K 0.15% 137
2025
Q2
$298K Sell
765
-20
-3% -$8.04K 0.2% 121
2025
Q1
$341K Hold
785
0.24% 108
2024
Q4
$290K Sell
785
-5
-0.6% -$2.09K 0.22% 115
2024
Q3
$411K Hold
790
0.31% 91
2024
Q2
$428K Sell
790
-39
-5% -$20.6K 0.36% 76
2024
Q1
$430K Buy
+829
New +$412K 0.36% 78

Other funds holding ELV

Keynote Financial Services's ELV Position: Q2 2026 in Review

Keynote Financial Services reduced its Elevance Health (ELV) stake by 1.1% in Q2 2026, selling an estimated $2.97K and leaving 697 shares worth $270K. The position accounts for 0.13% of the portfolio, ranked #145.

Keynote Financial Services first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $430K in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Keynote Financial Services held 697 shares of Elevance Health worth $270K as of Q2 2026.
  • Keynote Financial Services sold 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
  • Elevance Health made up 0.13% of Keynote Financial Services's portfolio in Q2 2026, its #145 holding.
  • Keynote Financial Services first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • Keynote Financial Services's Elevance Health position peaked at $430K in Q1 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.